Pathologist's health-care value in the triage of Oncotype DX® testing: a value-based pathology study of tumour biology with outcomes.

David J DabbsBeth Z ClarkKate SerdyAgnieszka OniskoAdam M BrufskySherie SmalleyStephen PerkinsRohit Bhargava

Published in: Histopathology (2018)

This unique study demonstrates that (i) pathologists add great value to triage breast cancer for GEPT; and (ii) can identify prospectively low-grade tumour biology with high sensitivity and high specificity for those cases which do not require chemotherapy (RS < 25) using MS and hormone receptor content.

Keyphrases

low grade
emergency department
healthcare
high grade
mass spectrometry
squamous cell carcinoma
type diabetes
radiation therapy
structural basis